Kathryn E. Falberg's Insider Trades & SAST Disclosures
Kathryn E. Falberg's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 200,801 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kathryn E. Falberg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 200,801 | 200,801 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 98.17 per share. | 13 Aug 2024 | 150,000 | 96,910 (0%) | 0% | 98.2 | 14,725,500 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 8,400 | 55,300 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 3,155 | 245,764 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 87.16 per share. | 28 May 2024 | 573 | 246,910 (0%) | 0% | 87.2 | 49,943 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 87.16 per share. | 28 May 2024 | 573 | 246,337 (0%) | 0% | 87.2 | 49,943 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 103,030 | 0 | - | - | Employee Stock Option Exercise (Right to Buy) | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 103,030 | 103,030 | - | - | Class B Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | 08 Mar 2024 | 103,030 | 0 | - | - | Class B Common Stock | ||
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | 08 Mar 2024 | 103,030 | 345,639 (0%) | 0% | 1.8 | 185,763 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 08 Mar 2024 | 102,935 | 242,704 (0%) | 0% | 81.9 | 8,430,377 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 82.36 per share. | 08 Mar 2024 | 95 | 242,609 (0%) | 0% | 82.4 | 7,824 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 50,504 | 40,100 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 6,800 | 46,900 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,238 | 241,011 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 62.52 per share. | 25 May 2023 | 799 | 241,810 (0%) | 0% | 62.5 | 49,953 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 62.52 per share. | 25 May 2023 | 799 | 242,609 (0%) | 0% | 62.5 | 49,953 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 30 Nov 2022 | 84,959 | 160,000 | - | 2.0 | 167,599 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 30 Nov 2022 | 75,041 | 75,041 | - | 1.9 | 139,088 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 30 Nov 2022 | 47,000 | 207,000 | - | 2.0 | 93,187 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.95 per share. | 30 Nov 2022 | 43,000 | 250,000 | - | 2.0 | 83,962 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,800 | 16,800 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 4,100 | 90,604 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,178 | 235,588 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 835 | 236,423 (0%) | 0% | 59.8 | 49,958 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 267 | 236,690 (0%) | 0% | 59.8 | 15,975 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 83 | 236,773 (0%) | 0% | 59.8 | 4,966 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 108.03 per share. | 19 Nov 2021 | 80,563 | 119,437 (0%) | 0% | 108.0 | 8,703,221 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 108.90 per share. | 19 Nov 2021 | 47,719 | 71,718 (0%) | 0% | 108.9 | 5,196,599 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 109.98 per share. | 19 Nov 2021 | 21,468 | 50,250 (0%) | 0% | 110.0 | 2,361,051 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 110.44 per share. | 19 Nov 2021 | 250 | 50,000 (0%) | 0% | 110.4 | 27,610 | Class A Common Stock |
| UroGen Pharma Ltd | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 3,000 | 86,504 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 390 | 3,031 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.65 per share. | 27 May 2021 | 78 | 3,109 (0%) | 0% | 639.7 | 49,893 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.64 per share. | 27 May 2021 | 25 | 3,134 (0%) | 0% | 639.6 | 15,991 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.71 per share. | 27 May 2021 | 7 | 3,141 (0%) | 0% | 639.7 | 4,478 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 28.35 per share. | 31 Mar 2021 | 20,000 | 102,106 (0%) | 0% | 28.3 | 566,996 | Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | 19 Nov 2020 | 20,000 | 0 | - | - | Class B Common Stock | ||
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 20,000 | 20,000 | - | - | Class B Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 20,000 | 10,303 | - | - | Employee Stock Option (Right to Buy) | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | 19 Nov 2020 | 20,000 | 22,641 (0%) | 0% | 0 | Class A Common Stock | ||
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 811.00 per share. | 19 Nov 2020 | 5,670 | 11,239 (0%) | 0% | 811 | 4,598,370 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 818.15 per share. | 19 Nov 2020 | 4,139 | 4,108 (0%) | 0% | 818.2 | 3,386,323 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 810.19 per share. | 19 Nov 2020 | 2,852 | 16,909 (0%) | 0% | 810.2 | 2,310,662 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 815.00 per share. | 19 Nov 2020 | 1,891 | 8,247 (0%) | 0% | 815 | 1,541,165 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 809.03 per share. | 19 Nov 2020 | 1,853 | 19,761 (0%) | 0% | 809.0 | 1,499,133 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 813.04 per share. | 19 Nov 2020 | 891 | 10,148 (0%) | 0% | 813.0 | 724,419 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 819.06 per share. | 19 Nov 2020 | 825 | 3,283 (0%) | 0% | 819.1 | 675,725 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 807.84 per share. | 19 Nov 2020 | 795 | 21,614 (0%) | 0% | 807.8 | 642,233 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 822.00 per share. | 19 Nov 2020 | 629 | 2,641 (0%) | 0% | 822 | 517,038 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 806.63 per share. | 19 Nov 2020 | 232 | 22,409 (0%) | 0% | 806.6 | 187,138 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 811.68 per share. | 19 Nov 2020 | 200 | 11,039 (0%) | 0% | 811.7 | 162,336 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 820.00 per share. | 19 Nov 2020 | 13 | 3,270 (0%) | 0% | 820 | 10,660 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 814.00 per share. | 19 Nov 2020 | 10 | 10,138 (0%) | 0% | 814 | 8,140 | Class A Common Stock |
| UroGen Pharma Ltd | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 3,000 | 83,504 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 901 | 2,377 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 249.66 per share. | 26 May 2020 | 180 | 2,557 (0%) | 0% | 249.7 | 44,939 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 249.66 per share. | 26 May 2020 | 64 | 2,621 (0%) | 0% | 249.7 | 15,978 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 249.65 per share. | 26 May 2020 | 20 | 2,641 (0%) | 0% | 249.7 | 4,993 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges